eXoZymes Inc. (EXOZ)
EXOZ trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.59
-9.11% on the day
Market cap
$42.7M
Nano cap
Revenue · 2023
$70K
No prior year to compare
Net income · 2023
-$2.0M
-2909.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2023.
Profile
| Field | Value |
|---|---|
| Ticker | EXOZ on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0002010788 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | NV |
Financials · 2023
| Line | Value |
|---|---|
| Revenue | $70K |
| Net income | -$2.0M |
| Operating income | -$1.8M |
| Net margin | -2909.1% |
| Operating margin | -2563.5% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $67K |
| Total assets | $3.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 609.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-30 |
| Latest annual report | 10-K | 2026-03-30 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-10-09 |
| Latest proxy | DEFA14A | 2026-09-28 |
Source: SEC EDGAR submissions feed, 120 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BSEM | BioStem Technologies Inc. | $2.25 | -7.79% | $42.0M |
| TIL | Instil Bio Inc. | $6.18 | -6.08% | $41.9M |
| INMB | INmune Bio Inc. | $1.68 | -5.62% | $46.6M |
| IMA | ImageneBio Inc. | $4.24 | -0.23% | $48.1M |
| CRBU | Caribou Biosciences Inc. | $0.4700 | -5.41% | $50.4M |
| ELOX | Eloxx Pharmaceuticals Inc. | $12.70 | -8.57% | $51.3M |
| BKHA | Black Hawk Acquisition Corporation | $12.48 | -4.00% | $51.8M |
| INKT | MiNK Therapeutics Inc. | $10.23 | -2.85% | $52.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier